Member Info for bigbench

1.9 200,000 JBER 07:52
1.9 250,000 PEEL 07:50
1.9 200,000 WINS 07:30
2 200,000 CANA 07:54
2 200,000 SCAP 07:3
2.1 200,000 MREX 07:56
2.15 250,000 CNKS 07:58
some big buys showing on advfn... seems the mm's have this pegged here even though 5.6million buys v only 48k sells

This work sees Tally in a strong position to achieve several milestones next quarter, including the crowdfunding campaign to go live next month, release of our upgraded pricing model for B2C customers, board expansion, updated branding, and developing our internal ledger architecture and B2B technology platform.

So we may actually finally get to find out what these milestones are?? Hmmmm

Guy... no i didn't see it but with many panicking and being concerned about the delay it was not a surprise but it was way oversold iMHO.... i didn't see the rise from 39p to 160 either... we all know how volatile and sensitive this stock is and how many traders jump in and out making the natural movement overly exaggerated... I'm not personally expecting news @ 7am Tuesday.. it may well drop in who knows.. I just makesure I'm never out even when it dips... i held all my shares when it dipped to 40p level...many jumped fearing further losses.... its never a loss until you sell...and im not selling anytime soon.

Now over 3m buys...no further sells... cant see how this isn't up 20%

blue soon my guess

Got a feeling when BTC does break that $60k level its on for a breakout..taking us with it

personally i cant see it dropping 50% if no news Tuesday.... its already well oversold at this silly price.. we know news is due to drop...its well overdue in many peoples book

Its been a while since I've seen such buying here...2.5mill bought... only 407 sold... should be up more than this id say but see how we go

lots of buying

01-Apr-21 10:27:03 1.806 140,000 Buy* 1.60 1.90 2,528 O
01-Apr-21 10:26:15 1.806 130,000 Buy* 1.60 1.90 2,348 O
01-Apr-21 10:17:14 1.811 28,000 Buy* 1.60 1.90 507.08 O
01-Apr-21 10:17:08 1.806 2,768 Buy* 1.60 1.90 49.99 O
01-Apr-21 10:10:11 1.806 2,768 Buy* 1.60 1.90 49.99 O
01-Apr-21 10:09:24 1.811 21,378 Buy* 1.60 1.90 387.16 O
01-Apr-21 10:09:05 1.62 409 Sell* 1.60 1.90 6.63 O
01-Apr-21 09:56:16 1.811 300,000 Buy* 1.60 1.90 5,433 O
01-Apr-21 09:52:17 1.811 55,219 Buy* 1.60 1.90 1,000 O
01-Apr-21 09:36:14 1.811 20,000 Buy* 1.60 1.90 362.20 O
01-Apr-21 09:31:34 1.874 17,556 Buy* 1.60 1.90 329.00 O
01-Apr-21 09:29:34 1.874 100,000 Buy* 1.60 1.90 1,874 O
01-Apr-21 09:04:26 1.8125 100,000 Buy* 1.60 1.90 1,813 O
01-Apr-21 09:00:37 1.874 20,000 Buy* 1.60 1.90 374.80 O
01-Apr-21 08:59:13 1.874 26,402 Buy* 1.60 1.90 494.77 O
01-Apr-21 08:50:45 1.811 7,439 Buy* 1.60 1.90 134.72 O
01-Apr-21 08:32:24 1.798 7,000 Buy* 1.60 1.90 125.86 O
01-Apr-21 08:29:38 1.874 37,038 Buy* 1.60 1.90 694.09 O
01-Apr-21 08:25:28 1.874 106,085 Buy* 1.60 1.90 1,988 O
01-Apr-21 08:20:28 1.874 12,833 Buy* 1.60 1.90 240.49 O
01-Apr-21 08:19:27 1.874 53,361 Buy* 1.60 1.90 999.99 O
01-Apr-21 08:16:04 1.88 270,640 Buy* 1.60 1.90 5,088 O
01-Apr-21 08:15:49 1.79 122,212 Buy* 1.60 1.90 2,188 O
01-Apr-21 08:15:35 1.84 162,394 Buy* 1.60 1.90 2,988 O
01-Apr-21 08:10:38 1.79 75,757 Buy* 1.60 1.90 1,356 O
01-Apr-21 08:01:16 1.785 138,330 Buy* 1.60 1.90 2,469 O
01-Apr-21 08:00:20 1.76 462,432 Buy* 1.60 1.90 8,139 O
31-Mar-21 16:37:45 1.85 500,000 Buy* 1.60 1.90 9,250 O

1.9 200,000 JBER 07:52
1.9 250,000 PEEL 07:50
1.9 200,000 WINS 07:30
2 200,000 CANA 07:54
2 200,000 SCAP 07:33
2.1 200,000 MREX 07:56
2.15 250,000 CNKS 07:58
SOU Live Trades

nice to see some official confidence here.... hot air or is there actually some action going on behind the scenes??

The Board and I are committed to progressing the Company to a successful IPO and we expect to provide in the end of Q2 update, the Company's plan to IPO in the second half of this year. Tally's IPO strategy is not just about seeing the Company's shares available for trading, it is to add another regulated environment for tally® customer confidence, enhance our platform for thought leadership about banking and FinTech, and as part of our mission toward the democratisation of money.

We hope that 2021 has started much brighter for all of our customers, shareholders, team members and other stakeholders and we look forward to Tally being part of the positive change to come."

CP did say a few times he would hope the relist price would be above the delist price but that depended on the valuation at the time of IPO/ relist... The secondary market is exactly that ... A platform where existing holders can sell to other holders and potential new investors at a priced negotiated between them.... I dint think it was a fixed price on the secondary market... Could be wrong but that's how I understood it.
Either way he should get a friggin move on!

.....
Signal Update Our system’s recommendation today is to BUY. The BULLISH THREE GAP DOWNS pattern finally received a confirmation because the prices crossed above the confirmation level which was at 67.5000, and our valid average buying price stands now at 68.1600.

some chunky trades gone through

Good morning Big Al... Glad the fishing is going ok, perfect weather for it..... Its nearly time for GDR to catch a whopper in the form of a FDA approval!.... Going to need a bigger net!

Lots of buying this morn....back to £ in no time.

Either way short term the trend would be upwards as we approach the 14th.... My view is Graham has negotiated these new terms over the last few months and now arrived at position suitable for all parties. What the ASAP will be if we announce its been accepted I'm don't know.... but surely well north of current price.

Q2 promises to be mega for GDR.... and that starts tomorrow!

Be nice to see this back in the 80's today.. Sooooooo oversold.

love it dixie
Shares of molecular diagnostics company Genedrive PLC (LON: GDR) are down 57% from their mid-February highs of 163p to their current trading price. Many investors are wondering whether now is a good time to buy.

Based on the company’s H1 earnings results and forward guidance, it is evident that the management team expects to have a stellar H2, which could fuel another rally. Bullish investors may find the current price very attractive from a long-term perspective.

Genedrive announced a significant shift in its business strategy towards developed countries with differentiated markets and product cycles with predictable revenue targets that could deliver excellent results in H2.

The company has several lucrative partnerships that could deliver significant contract wins in H2, such as its partnership with Mountain Horse solutions that could see it win US military contracts in future.

Genedrive is could also generate significant revenues from its partnership with Beckman Coulter, which will distribute its high-throughput Covid-19 PCR kit in the United States and Europe using upper respiratory viral samples.

Beckman Coulter’s deal seeks to capitalise on the ongoing COVID-19 testing needs as the global vaccination campaigns continue and countries start relaxing lockdown restrictions, which is likely to trigger a surge in global travel.

Genedrive’s current fundamentals point to excellent performance in the second half of its financial year and investors. The company’s shares are trading at an attractive valuation, given its positive prospects.